Cyclacel Pharmaceuticals Inc (CYCC)
0.40
-0.06
(-12.09%)
USD |
NASDAQ |
Nov 14, 10:25
Cyclacel Pharmaceuticals Price: 0.40 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 0.4158 | 0.5213 | 0.3712 | 0.455 | 12.60M |
| Nov 12, 2024 | 0.4433 | 0.4433 | 0.3934 | 0.41 | 3.348M |
| Nov 11, 2024 | 0.455 | 0.4733 | 0.4301 | 0.449 | 602797.0 |
| Nov 08, 2024 | 0.411 | 0.50 | 0.3918 | 0.481 | 2.732M |
| Nov 07, 2024 | 0.48 | 0.519 | 0.375 | 0.4257 | 3.037M |
| Nov 06, 2024 | 0.4422 | 0.4465 | 0.401 | 0.4151 | 469186.0 |
| Nov 05, 2024 | 0.5045 | 0.5045 | 0.4326 | 0.4421 | 896189.0 |
| Nov 04, 2024 | 0.6145 | 0.6246 | 0.5005 | 0.505 | 661329.0 |
| Nov 01, 2024 | 0.632 | 0.6364 | 0.60 | 0.6269 | 216617.0 |
| Oct 31, 2024 | 0.64 | 0.6670 | 0.62 | 0.649 | 206667.0 |
| Oct 30, 2024 | 0.6621 | 0.686 | 0.6351 | 0.657 | 617995.0 |
| Oct 29, 2024 | 0.659 | 0.70 | 0.601 | 0.6801 | 498637.0 |
| Oct 28, 2024 | 0.8412 | 0.8599 | 0.665 | 0.70 | 1.452M |
| Oct 25, 2024 | 0.85 | 0.90 | 0.79 | 0.832 | 766714.0 |
| Oct 24, 2024 | 1.00 | 1.01 | 0.81 | 0.8707 | 1.933M |
| Oct 23, 2024 | 1.64 | 1.67 | 1.01 | 1.06 | 11.96M |
| Oct 22, 2024 | 1.46 | 2.49 | 1.38 | 1.43 | 27.68M |
| Oct 21, 2024 | 1.24 | 1.44 | 1.21 | 1.32 | 2.444M |
| Oct 18, 2024 | 1.06 | 1.99 | 1.04 | 1.14 | 14.47M |
| Oct 17, 2024 | 1.05 | 1.19 | 0.95 | 1.01 | 932112.0 |
| Oct 16, 2024 | 0.86 | 1.05 | 0.8578 | 0.99 | 207109.0 |
| Oct 15, 2024 | 0.824 | 0.87 | 0.79 | 0.8134 | 30801.00 |
| Oct 14, 2024 | 0.80 | 0.824 | 0.79 | 0.80 | 19933.00 |
| Oct 11, 2024 | 0.80 | 0.8079 | 0.76 | 0.80 | 19775.00 |
| Oct 10, 2024 | 0.811 | 0.8132 | 0.75 | 0.7952 | 23944.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.40
Minimum
Nov 14 2024
274.50
Maximum
Jan 10 2020
49.57
Average
25.35
Median
Sep 02 2022
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.722 |
| Palatin Technologies Inc | 1.08 |
| iBio Inc | 2.24 |
| Theriva Biologics Inc | 1.33 |
| Oragenics Inc | 0.335 |
Price Related Metrics
| PS Ratio | 6.042 |
| Price to Book Value | 0.7905 |
| Earnings Yield | -4.10K% |
| Market Cap | 0.7897M |